A Randomized Controlled Trial to Determine Whether Treatment with a Neutral pH,Low Glucose Degradation Product Dialysate (Balance) Prolongs Residual Renal Function in Peritoneal Dialysis Patients
Restricted accessResearch articleFirst published online January, 2006
A Randomized Controlled Trial to Determine Whether Treatment with a Neutral pH,Low Glucose Degradation Product Dialysate (Balance) Prolongs Residual Renal Function in Peritoneal Dialysis Patients
WilliamsJ.D., TopleyN., CraigK.J., MackenzieR.K., PischetsriederM., LageC.The Euro-Balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.Kidney Int2004; 66: 408–18.
4.
BargmanJ.M., ThorpeK.E., ChurchillD.N.Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study.J Am Soc Nephrol2001; 12: 2158–62.
5.
PaniaguaR., AmatoD., VoneshE., Correa-RotterR., RamosA., MoranJ.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.J Am Soc Nephrol2002; 13: 1307–20.
6.
TermorshuizenF., KorevaarJ.C., DekkerF.W., Van ManenJ.G., BoeschotenE.W., KredietR.T.The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2.Am J Kidney Dis2003; 41: 1293–302.
